Pluton Biosciences, Inc. — Form D
Pluton Biosciences, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-02. The offering totals $17.6M, of which $17.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-06-02
- Form: D
- Accession: 0001759355-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.6M
- Amount sold: $17.6M
- Minimum investment: $75K
- Investors: 12
- Date of first sale: 2023-02-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-483201
Issuer
- Name: Pluton Biosciences, Inc.
- CIK: 0001759355
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 11754 WESTLINE INDUSTRIAL DRIVE, ST. LOUIS, MO, 63146
- Phone: 800-688-9144
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Elizabeth Gallegos | Director | ST. LOUIS, MO |
| Michael Gillespie | Director | Bethesda, MD |
| Barry Goldman | Director | ST. LOUIS, MO |
| Neal Gutterson | Director | Chicago, IL |
| Charles Lin | Director | ST. LOUIS, MO |
| Clay Mitchell | Director | Santa Rosa, CA |
| Gerald Steiner | Director | ST. LOUIS, MO |
| Elizabeth Gallegos | Executive Officer | ST. LOUIS, MO |
| Barry Goldman | Executive Officer | ST. LOUIS, MO |
| Glendon Schuster | Director | Clayton, MO |
| Charles Walch | Executive Officer | St. Louis, MO |
| Steven Slater | Director | St. Louis, MO |
| Steven Slater | Executive Officer | St. Louis, MO |
| Wesley Selke | Director | St. Louis, MO |
| Charlie Walch | Director | St. Louis, MO |
| Charlie Walch | Executive Officer | St. Louis, MO |
Other filings by this issuer (2)
More